Thymoquinone: an emerging natural drug with a wide range of medical applications
- PMID: 25859298
- PMCID: PMC4387230
Thymoquinone: an emerging natural drug with a wide range of medical applications
Abstract
Nigella sativa has attracted healers in ancient civilizations and researchers in recent times. Traditionally, it has been used in different forms to treat many diseases including asthma, hypertension, diabetes, inflammation, cough, bronchitis, headache, eczema, fever, dizziness and influenza. Experimentally, it has been demonstrated that N. sativa extracts and the main constituent of their volatile oil, thymoquinone, possess antioxidant, anti-inflammatory and hepatoprotective properties. In this review we aimed at summarizing the most recent investigations related to a few and most important effects of thymoquinone. It is concluded that thymoquinone has evidently proved its activity as hepatoprotective, anti-inflammatory, antioxidant, cytotoxic and anti-cancer chemical, with specific mechanisms of action, which provide support to consider this compound as an emerging drug. Further research is required to make thymoquinone a pharmaceutical preparation ready for clinical trials.
Keywords: Anti-cancer; Anti-inflammatory; Antioxidant; Nigella sativa; Thymoquinone.
Similar articles
-
Black Cumin (Nigella sativa) and Its Active Constituent, Thymoquinone: An Overview on the Analgesic and Anti-inflammatory Effects.Planta Med. 2016 Jan;82(1-2):8-16. doi: 10.1055/s-0035-1557838. Epub 2015 Sep 14. Planta Med. 2016. PMID: 26366755 Review.
-
Black cumin (Nigella sativa) and its constituent (thymoquinone): a review on antimicrobial effects.Iran J Basic Med Sci. 2014 Dec;17(12):929-38. Iran J Basic Med Sci. 2014. PMID: 25859296 Free PMC article. Review.
-
Preclinical and clinical effects of Nigella sativa and its constituent, thymoquinone: A review.J Ethnopharmacol. 2016 Aug 22;190:372-86. doi: 10.1016/j.jep.2016.06.061. Epub 2016 Jun 27. J Ethnopharmacol. 2016. PMID: 27364039 Review.
-
Molecular mechanisms and signaling pathways of black cumin (Nigella sativa) and its active constituent, thymoquinone: a review.Mol Biol Rep. 2023 Jun;50(6):5439-5454. doi: 10.1007/s11033-023-08363-y. Epub 2023 May 8. Mol Biol Rep. 2023. PMID: 37155017 Review.
-
Anticancer activity of Nigella sativa (black seed) - a review.Am J Chin Med. 2011;39(6):1075-91. doi: 10.1142/S0192415X1100941X. Am J Chin Med. 2011. PMID: 22083982 Review.
Cited by
-
Therapeutic Potential of Thymoquinone in Triple-Negative Breast Cancer Prevention and Progression through the Modulation of the Tumor Microenvironment.Nutrients. 2021 Dec 25;14(1):79. doi: 10.3390/nu14010079. Nutrients. 2021. PMID: 35010954 Free PMC article. Review.
-
Thymoquinone Enhances Paclitaxel Anti-Breast Cancer Activity via Inhibiting Tumor-Associated Stem Cells Despite Apparent Mathematical Antagonism.Molecules. 2020 Jan 20;25(2):426. doi: 10.3390/molecules25020426. Molecules. 2020. PMID: 31968657 Free PMC article.
-
Thymoquinone abrogates methamphetamine-induced striatal neurotoxicity and hyperlocomotor activity in mice.Res Pharm Sci. 2021 Jun 30;16(4):391-399. doi: 10.4103/1735-5362.319577. eCollection 2021 Aug. Res Pharm Sci. 2021. PMID: 34447447 Free PMC article.
-
Thymoquinone inhibits growth of human medulloblastoma cells by inducing oxidative stress and caspase-dependent apoptosis while suppressing NF-κB signaling and IL-8 expression.Mol Cell Biochem. 2016 May;416(1-2):141-55. doi: 10.1007/s11010-016-2703-4. Epub 2016 Apr 15. Mol Cell Biochem. 2016. PMID: 27084536
-
Hypothyroidism-Induced Nonalcoholic Fatty Liver Disease (HIN): Mechanisms and Emerging Therapeutic Options.Int J Mol Sci. 2020 Aug 18;21(16):5927. doi: 10.3390/ijms21165927. Int J Mol Sci. 2020. PMID: 32824723 Free PMC article. Review.
References
-
- Ali BH, Blunden G. Pharmacological and toxicological properties of Nigella sativa. Phytother Res. 2003;17:299–305. - PubMed
-
- Entok E, Ustuner MC, Ozbayer C, Tekin N, Akyuz F, Yangi B, et al. Anti-inflammatuar and anti-oxidative effects of Nigella sativa L. FDG-PET imaging of inflammation. Mol Biol Rep. 2014;41:2827–2834. - PubMed
-
- Jazieh AR, Al Sudairy R, Abulkhair O, Alaskar A, Al Safi F, Sheblaq N, et al. Use of complementary and alternative medicine by patients with cancer in Saudi Arabia. J Altern Complement Med. 2012;8:1045–1049. - PubMed
-
- Soleimani H, Ranjbar A, Baeeri M, Mohammadirad A, Khorasani R, Yasa N, et al. Rat plasma oxidation status after Nigella sativa L. botanical treatment in CCL(4)-treated rats. Toxicol Mech Methods. 2008;18:725–731. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources